Isoxazole combretastin derivatives for the treatment of disorders

Details for Australian Patent Application No. 2006214164 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Koya, Keizo; Jiang, Jun; Wu, Yaming; Chen, Shoujun; Du, Zhenjian; Foley, Kevin; Sun, Lijun; Zhang, Mei; Ying, Weiwen; Inoue, Takayo; Li, Hao; Borella, Christopher

Agent Davies Collison Cave

Pub. Number AU-B-2006214164

PCT Pub. Number WO2006/089177

Priority 60/733,912 04.11.05 US; 60/653,890 17.02.05 US; 60/660,112 08.03.05 US

Filing date 16 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 9 December 2010

International Classifications

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/089177 Priority application(s): WO2006/089177

9 December 2010 Application Accepted

  Published as AU-B-2006214164

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214166-Transmucosal administration of drug compositions for treating and preventing disorders in animals

2006214142-Fitting of brightness in a visual prosthesis